Monday, June 15, 2026

Samsung’s Bespoke AI Appliances: How They Achieve Up to 70% Energy Savings in 2026

Samsung showcased AI-powered energy-efficient appliances at The Brief Milan seminar, targeting eco-conscious European consumers.

How to Prevent Gum Disease During Seasonal Shifts

Seasonal changes can weaken immunity, increasing oral health risks like gum disease. Early detection and good hygiene are crucial.

Top 10 Agricultural Units in North Korea Revealed: Insights from the 2026 Conference

North Korea's Agricultural Summary Meeting reviewed last year's achievements, highlighting high-yield farms and scientific farming advancements.

Tag: pharmaceutical

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

DongKoo Bio & Pharma Unveils TERABIOTICS PRO 1.06 to Strengthen Health Supplement Business

Donggu Bio Pharmaceutical announces the launch of its new 5th generation probiotic product, TERABIOTICS PRO 1.06.

AriBio Advances Global Alzheimer’s Strategy With Multibillion-Dollar AR1001 Licensing Deal

AriBio secures a $4.67 billion licensing deal for Alzheimer's drug AR1001 with Puxing Pharmaceutical, aiming for global commercialization.

A Record Year in China Is Giving Hanmi Pharmaceutical More Firepower for What’s Next

Hanmi Pharmaceutical's Chinese subsidiary surpassed $290M in sales, contributing significantly to the group's growth and future investments.

Dong-A University Hospital Launches AI-Driven thynC Monitoring System

Dong-A University Hospital launches AI-powered smart bed system thynC, enhancing patient monitoring and safety across general wards.

Fexuclue 40mg: How This New GERD Treatment is Revolutionizing Healthcare in Indonesia

Daewoong Pharmaceutical's Fexuclue receives approval in Indonesia for treating GERD, aiming for rapid expansion in the market.

AACR 2026: How Korean Biotech Firms Are Leading the Charge in Cancer Research

AACR 2026 in San Diego will showcase South Korea's cancer tech innovations, featuring firms like Hanmi and Samsung Biologics.

Imeroprubart vs. Batoclimab: Which Treatment Will Revolutionize Graves’ Disease Management?

HanAll Biopharma's Imeroprubart targets Graves' disease, showing promise with IgG suppression and user-friendly auto-injector delivery.

How Hanmi’s Dual Inhibitor HM97662 is Revolutionizing Cancer Treatment: Key Insights from AACR 2026

Hanmi Pharmaceutical to present nine groundbreaking cancer research studies at AACR 2026, showcasing innovative therapies and AI-driven analytics.

Stoboclo: How This New Osteoporosis Treatment Achieved 11.8 Billion KRW in Sales in Just One Year

Daewoong Pharmaceutical's Stoboclo, a biosimilar for osteoporosis, achieved 11.8 billion KRW in sales in its first year, marking rapid growth.

Revolutionizing Patient Care: How thynC AI Monitoring Transforms Hospital Safety in Seoul

Seoul Sungsim Hospital adopts AI bed monitoring system thynC to enhance patient safety and streamline nursing care management.

April 2026: Major Regulatory Actions on Herbal Patches and Antibiotics in South Korea

The FDA suspended manufacturing and sales of several products for regulatory violations, including herbal patches and antibiotic tablets.

A Future Of 24/7 Health Monitoring: Korea Pushes AI-Driven Care Forward

Daewoong Pharmaceutical showcases its digital healthcare innovations, achieving significant market share with AI solutions for patient care.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.